Ayman Hijazy

Multimodal AI-driven analysis in breast and lung cancer: insights from the OPTIMA prototyping workshop

Maryam Abdollahyan, Emanuela Gadaleta, L. Stanley James, Graeme J. Thorn et autres

This paper reports on insights from the OPTIMA (Optimal Treatment for Patients with Solid Tumours in Europe Through Artificial Intelligence) prototyping workshop held in Berlin from November 6 to November 8, 2024. Through integrated analysis of clinical, genomic, imaging and pathology data, …

gb, de, us, es, it, nl, fr (code pays fourni par la source)

Corrigendum to “Treatment Trajectories in Metastatic Hormone-sensitive Prostate Cancer: A PIONEER+ Big Data Analysis” [Eur. Urol. Oncol. 8(5) (2025) 1340–1349]

Rossella Nicoletti, Alex Qinyang Liu, Susan Evans-Axelsson, Asieh Golozar et autres

The authors regret the error and request the above correction to the authorship. The authors would like to apologise for any inconvenience caused.

hk, it, us, nl, at, cz, gb, fi, es, se, de (code pays fourni par la source)

Real-world Evidence on Baseline Characteristics and Treatment in Metastatic Hormone-sensitive Prostate Cancer: Findings from the PIONEER 2.0 Big Data Investigation Group

Juan Gómez Rivas, Susan Evans‐Axelsson, Ayman Hijazy, Katharina Beyer et autres

Background and objective: As first-line therapies for metastatic hormone-sensitive prostate cancer (mHSPC) expand, real-world insights into the baseline characteristics and treatment patterns of mHSPC patients are critical. This study characterises baseline patient profiles and treatment patterns in a multinational real-world cohort from …

es, ch, de, fr, nl, hk, us, jp, it, gb, at, pl (code pays fourni par la source)

Observational Health Data Analysis of the Cardiovascular Adverse Events of Systemic Treatment in Patients with Metastatic Hormone-sensitive Prostate Cancer: Big Data Analytics Using the PIONEER Platform

Paweł Rajwa, Angelika Borkowetz, Thomas Abbott, Andrea Alberti et autres

at, gb, de, nl, it, se, hu, us, fr, ee, es, dk (code pays fourni par la source)

Observational Health Data Analysis of the Cardiovascular Adverse Events of Systemic Treatment in Patients with Metastatic Hormone-sensitive Prostate Cancer: Big Data Analytics Using the PIONEER Platform

Pawel Rajwa, Angelika Borkowetz, Thomas Abbott, Andrea Alberti et autres

Treatment Trajectories in Metastatic Hormone-sensitive Prostate Cancer: A PIONEER+ Big Data Analysis

Rossella Nicoletti, Alex Qinyang Liu, Susan Evans‐Axelsson, Asieh Golozar et autres

BACKGROUND AND OBJECTIVE: The treatment landscape for metastatic hormone-sensitive prostate cancer (mHSPC) is evolving rapidly. Real-world data (RWD) are essential to understand actual treatment use and outcomes. This study aimed to describe treatment trajectories and clinical outcomes in a large, multicenter RWD …

hk, it, us, nl, at, cz, gb, fi, es, se, de (code pays fourni par la source)

MP16-04 SYSTEMIC TREATMENT PRESCRIPTION AND SWITCH PATTERNS IN MHSPC BASED ON REAL WORLD EVIDENCE: RESULTS FROM THE PIONEER+ BIG DATA CONSORTIUM FOR PROSTATE CANCER

Rossella Nicoletti, Alex Qinyang Liu, Thomas A. Abbott, Qi Feng et autres

PD16-02 INSIGHTS FROM THE PIONEER+ BIG DATA CONSORTIUM FOR PROSTATE CANCER: BASELINE CHARACTERISTICS AND MEDICATION PROFILE VARIATIONS IN MHSPC

Alex Qinyang Liu, Rossella Nicoletti, Thomas A. Abbott, Qi Feng et autres

P183 – Differences in baseline characteristics and medication profiles in mHSPC patients based on real world evidence: PIONEER 2.0 Big Data Consortium for prostate cancer

A. Q. Liu, R. Nicoletti, T. Abbott, Qiushi Feng et autres

P321 – Systemic treatment prescription and treatment switch patterns in mHSPC based on real world evidence: Insight from PIONEER +

Rossella Nicoletti, A. Q. Liu, Stefan Axelsson, Asieh Golozar et autres

P135 Big data analysis of adverse events in metastatic hormone-sensitive prostate cancer systemic treatment using the PIONEER platform

P. Rajwa, Angelika Borkowetz, Thomas A. Abbott, Andrea Alberti et autres

Trends in incidence, prevalence, and survival of breast cancer in the United Kingdom from 2000 to 2021

Nicola L. Barclay, Edward Burn, Antonella Delmestri, Talita Duarte‐Salles et autres

Breast cancer is the most frequently diagnosed cancer in females globally. However, we know relatively little about trends in males. This study describes United Kingdom (UK) secular trends in breast cancer from 2000 to 2021 for both sexes. We describe a population-based …

gb, es, us, bd, cz, nl, de, se, fr, ee, it, at, be (code pays fourni par la source)